- Free from Publisher CJ Crespo, E Smit, A Snelling, CT Sempos, … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Our results show that postmenopausal women with diabetes had increased
dyslipidemia compared with nondiabetic women. Among diabetic women, current
users of HRT had significant different lipid and glucose control levels ... Cited by 30 - Related articles - BL Direct - All 8 versions
K Saglam, Z Polat, MI Yilmaz, M Gulec, SB … - Endocrine, 2002 - Springer Received April 15, 2002; Revised June 19, 2002; Accepted June 28, 2002. Author
to whom all correspondence and reprint requests should be addressed: Kenan
Saglam, Department of Internal Medicine, Gülhane Military Medical Academy, ... Cited by 17 - Related articles - BL Direct - All 3 versions
DAC Araújo, MLF Farias, ATL Andrade - Climacteric, 2002 - informahealthcare.com Page 1. Effects of transdermal and oral estrogen replacement on lipids and glucose
metabolism in postmenopausal women with type 2 diabetes mellitus ... Cited by 28 - Related articles - BL Direct - All 4 versions
- ►endojournals.org KE Friday, C Dong, RU Fontenot - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc When compared with 8 weeks of placebo, estrogen reduced fasting serum glucose
(7.2 ± 0.3 vs. 8.4 ± 0.4 mmol/L, P = 0.0003), glycated hemoglobin (8.7 ± 0.4%
vs. 9.3 ± 0.4%, P = 0.04), total cholesterol (5.27 ± 0.20 vs. 5.50 ± ... Cited by 60 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org A Ferrara, AJ Karter, LM Ackerson, JY Liu, JV … - Diabetes care, 2001 - Am Diabetes Assoc RESULTS—The mean age was 64.7 years (SD ± 8.7). The study cohort comprised
55% non-Hispanic whites, 14% non-Hispanic blacks, 12% Hispanics, 11% Asians, 4%
“other” ethnic groups, and 4% with missing ethnicity data. Current HRT ... Cited by 53 - Related articles - BL Direct - All 6 versions
PJ Manning, A Allum, S Jones, WHF … - Archives of Internal Medicine, 2001 - archinte.highwire.org Background Postmenopausal women with diabetes are at high risk for
cardiovascular disease, compared with their nondiabetic counterparts. Combined
continuous hormone replacement therapy (HRT) is associated with ... Cited by 46 - Related articles - BL Direct - All 5 versions
B Andersson, LÅ Mattsson - Acta obstetricia et gynecologica Scandinavica, 1999 - informahealthcare.com Page 1. Acta Obstet Gynecol Scand 1999; 78: 260–261 Copyright C Acta Obstet
Gynecol Scand 1999 Printed in Denmark – all rights reserved ... Cited by 15 - Related articles - BL Direct - All 8 versions
- Free from Publisher J Buse, L Raftery - Diabetes care, 2002 - Am Diabetes Assoc Timing is everything. When the authors prepared the manuscript, when the
reviewers and editors accepted it, and in fact when we were asked to prepare
this editorial, studies like these were sufficient reason for health care ... Cited by 4 - Related articles - BL Direct - All 5 versions
DA Darko, A Dornhorst, G Kennedy, RC … - Diabetes research and clinical practice, 2001 - Elsevier Aims: To compare the effect of a fixed combination of an oestrogen (17-β
oestradiol) with a cyclical progestagen (norethisterone) on glycaemic control,
plasma lipoproteins and haemostatic factors in women with Type 2 diabetes. ... Cited by 18 - Related articles - All 10 versions
- ►endojournals.org M Perera, N Sattar, JR Petrie, C Hillier, M … - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc People with type 2 diabetes have a substantially increased risk of coronary
heart disease (CHD). Short-term studies with unopposed oral estradiol in women
with diabetes have suggested potentially beneficial effects on lipids, ... Cited by 55 - Related articles - BL Direct - All 11 versions
